Shu-HuaWangMD

Infectious Disease • Columbus, OH

Healthcare Associated Infections, International Health, Travel & Tropical, Mycobacterial Disease

Associate Professor, Internal Medicine, Ohio State University College of Medicine

Join to view full profile

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

Office
1581 Dodd Dr
Fl 4
Columbus, OH 43210
Phone+1 614-293-4854

Fax+1 614-293-8102

Education & Training

Tulane UniversityPost-Doctoral Fellowship, Infectious Disease, 2004 - 2005
Louisiana State University School of MedicineFellowship, Infectious Disease, 2002 - 2004
University of Wisconsin Hospitals and ClinicsFellowship, Infectious Disease, 2000 - 2001
Medical College of WisconsinClass of 1996

Certifications & Licensure

OH State Medical License 2005 - 2025
WI State Medical License 1997 - 2007
LA State Medical License 2002 - 2006
CA State Medical License Active through 1998
American Board of Internal Medicine Infectious Disease

Clinical Trials

Clinical Concordance Evaluation of T-SPOT®.TB Assay Performance (T-Cell SelectTM Study) Start of enrollment: 2019 Nov 04
Completed

Publications & Presentations

PubMed

66 citations
High Rate of Treatment Completion in Program Settings With 12-Dose Weekly Isoniazid and Rifapentine for Latent Mycobacterium tuberculosis Infection.
Amy L. Sandul, Nwabunie Nwana, J Mike Holcombe, Mark N. Lobato, Suzanne M. Marks
Clinical Infectious Diseases. 2017-10-01
8 citations
Predictors of unfavorable outcome in neurosyphilis: Multicenter ID-IRI Study.
Derya Ozturk-Engin, Hakan Erdem, Rodrigo Hasbun, Shu-Hua Wang, Hulya Tireli
European Journal of Clinical Microbiology & Infectious Diseases. 2019-01-01
93 citations
Characterization of Host and Microbial Determinants in Individuals with Latent Tuberculosis Infection Using a Human Granuloma Model
Evelyn Guirado, Uchenna Mbawuike, Tracy L. Keiser, Jesus Arcos, Abul K. Azad
Mbio. 2015-02-27

Press Mentions

Ohio State Zeroes in on Improving Bovine Tuberculosis TestingJuly 31st, 2019
High Completion Rate for Isoniazid-Rifapentine in Patients with Latent TBOctober 9th, 2017
With Short Course of TB Prevention for People Living with HIV, Completion SoarsAugust 25th, 2021